24 August 2024 2 1K Report

"The integration of biobanks in pharmaceutical research has opened new avenues for personalized medicine and drug development. By storing and managing biological samples linked to extensive clinical data, biobanks offer significant potential for identifying biomarkers, understanding disease mechanisms, and developing targeted therapies. However, challenges such as data standardization, ethical considerations, and the need for robust infrastructure remain barriers to their full utilization. What are the key factors driving or limiting the effective use of biobanks in advancing pharmaceutical research and personalized medicine?"

Similar questions and discussions